title: Metabolism of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 by blood derived macrophages from a patient with alveolar rhabdomyosarcoma during short-term culture and 1 alpha,25-dihydroxyvitamin D3 after long-term culture.
abstract: We have examined the ability of blood-derived monocytes and macrophages isolated from a patient with alveolar rhabdomyosarcoma and hypercalcaemia, to form 24,25-dihydroxyvitamin D3 (24,25(OH)2D3) or 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) from 25-hydroxyvitamin D3 (25(OH)D3). Adherent monocyte-macrophage cells incubated with 25(OH)D3 over the initial 2 days in culture synthesized 1.9 pmol 24,25(OH)2D3/h/incubation (representing 0.63 pmol/h/10(6) cells), whereas macrophages synthesized 1.03 and 1.15 pmol 1 alpha,25(OH)2D3/h/incubation after 1 and 4 weeks in culture respectively. In a further experiment synthesis of 1 alpha,25(OH)2D3 by long-term cultured macrophages fell from 2.25 to 0.04 pmol/h/incubation following exposure to 10 nM 1 alpha,25(OH)2D3 for 7 days, whereas 24,25(OH)2D3 synthesis was induced (0.46 pmol/h/incubation). The vitamin D3 metabolites were identified by co-chromatography with authentic 24,25(OH)2D3 or 1 alpha,25(OH)2D3 in three different high-performance liquid chromatography systems. Serum 1 alpha,25(OH)2D3 in the patient was markedly suppressed at 5 pg/ml (normal 20-50 pg/ml) indicating that raised 1 alpha,25(OH)2D3 was not the cause of the hypercalcaemia, but rather, that raised calcium may have suppressed renal 1 alpha,25(OH)2D3 synthesis. Administration of APD (3-amino-1-hydroxypropylidine-1,1-bisphosphonate) corrected the hypercalcaemia in the patient suggesting that increased bone resorption was responsible for the raised calcium. The results of this study show for the first time that immature blood derived monocyte-macrophage cells can synthesize 24,25(OH)2D3 before they mature into macrophages able to synthesize 1 alpha,25(OH)2D3.
authors.affiliation: University Department of Medicine, Royal Infirmary, Manchester, England.
authors.forename: M E
authors.initials: ME
authors.lastname: Hayes
authors.forename: D
authors.initials: D
authors.lastname: Bayley
authors.forename: M
authors.initials: M
authors.lastname: Drayson
authors.forename: A J
authors.initials: AJ
authors.lastname: Freemont
authors.forename: J
authors.initials: J
authors.lastname: Denton
authors.forename: M
authors.initials: M
authors.lastname: Davies
authors.forename: E B
authors.initials: EB
authors.lastname: Mawer
mesh_terms: D015650:24,25-Dihydroxyvitamin D 3 / Q000096:biosynthesis / Q000378:metabolism*; D002112:Calcifediol / Q000096:biosynthesis / Q000378:metabolism*; D002117:Calcitriol / Q000378:metabolism*; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D006934:Hypercalcemia / Q000097:blood; D008175:Lung Neoplasms / Q000378:metabolism*; D008264:Macrophages / Q000378:metabolism*; D012208:Rhabdomyosarcoma / Q000378:metabolism*
chemical_list: D015650:24,25-Dihydroxyvitamin D 3; D002117:Calcitriol; D002112:Calcifediol